Efficacy and Safety of Maribavir Dosed at 100 mg Orally Twice Daily for the Prevention of Cytomegalovirus Disease in Liver Transplant Recipients: A Randomized, Double-Blind, Multicenter Controlled Trial
- Author
- WINSTON, D. J1 ; SALIBA, F2 ; NAVASA, M11 ; TROISI, R. I12 ; CHEN, H13 ; VILLANO, S. A13 ; UKNIS, M. E13 ; BLUMBERG, E3 ; ABOULJOUD, M4 ; GARCIA-DIAZ, J. B5 ; GOSS, J. A6 ; CLOUGH, L7 ; AVERY, R8 ; LIMAYE, A. P9 ; ERICZON, B. G10
[1] Department of Medicine, UCLA Center for the Health Sciences, Los Angeles, CA, United States
[2] Hospital Paul Brousse, Villejuif, France
[3] University of Pennsylvania, Philadelphia, PA, United States
[4] Henry Ford Transplant Institute, Detroit, MI, United States
[5] Ochsner Clinic Foundation, New Orleans, LA, United States
[6] Baylor Collge of Medicine, Houston, TX, United States
[7] University of Kansas Medical Center, Kansas City, KS, United States
[8] Cleveland Clinic Foundation, Cleveland, OH, United States
[9] University of Washington, Seattle, WA, United States
[10] Karolínska Universitetssjukhúset-Huddinge, Stockholm, Sweden
[11] Hospital Clinic de Barcelona, Barcelona, Spain
[12] UZ Gent, Gent, Belgium
[13] ViroPharma, Inc., Exton, PA, United States
Clinical Study Group - Source
American journal of transplantation (Print). 2012, Vol 12, Num 11, pp 3021-3030, 10 p ; ref : 26 ref
- ISSN
- 1600-6135
- Scientific domain
- Graft, transplantation
- Publisher
- Wiley, Hoboken, NJ
- Publication country
- United States
- Document type
- Article
- Language
- English
- Author keyword
- Cytomegalovirus Maribavir liver transplantation prevention
- Keyword (fr)
- Antiviral Complication Cytomegalovirus humain Efficacité traitement Essai clinique Etude double insu Etude multicentrique Foie Homotransplantation Infection opportuniste Maribavir Prévention Randomisation Sécurité Toxicité Traitement Virose Voie orale Essai randomisé contrôlé Transplantation hépatique Analogue de nucléoside Appareil digestif Betaherpesvirinae Chirurgie Greffe Herpesviridae Infection Virus
- Keyword (en)
- Antiviral Complication Human cytomegalovirus Treatment efficiency Clinical trial Double blind study Multicenter study Liver Homotransplantation Opportunistic infection Maribavir Prevention Randomization Safety Toxicity Treatment Viral disease Oral administration Randomized controlled trial Liver transplantation Nucleoside analog Digestive system Betaherpesvirinae Surgery Graft Herpesviridae Infection Virus
- Keyword (es)
- Antiviral Complicación Human cytomegalovirus Eficacia tratamiento Ensayo clínico Estudio doble ciego Estudio multicéntrico Hígado Homotrasplante Infección oportunista Maribavir Prevención Aleatorización Seguridad Toxicidad Tratamiento Virosis Vía oral Ensayo aleatorio controlado Análogo nucleósido Aparato digestivo Betaherpesvirinae Cirugía Injerto Herpesviridae Infección Virus
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B05 Infectious diseases / 002B05C Viral diseases
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B25 Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases / 002B25G Surgery of the digestive system / 002B25G03 Liver, biliary tract, pancreas, portal circulation, spleen
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B30 Public health. Hygiene-occupational medicine / 002B30A Public health. Hygiene / 002B30A03 Prevention and actions
- Discipline
- Infectious pathology Public health. Hygiene-occupational medicine Surgery. Transplants, organs and tissues grafting. Graft pathologies
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 26735987
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1111/j.1600-6143.2012.04231.x 
https://dx.doi.org/10.1111/j.1600-6143.2012.04231.x
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:32:\"10.1111\/j.1600-6143.2012.04231.x\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:202:\"Efficacy and Safety of Maribavir Dosed at 100 mg Orally Twice Daily for the Prevention of Cytomegalovirus Disease in Liver Transplant Recipients: A Randomized, Double-Blind, Multicenter Controlled Trial\";s:9:\"\u0000*\u0000jtitle\";s:43:\"American journal of transplantation (Print)\";s:9:\"\u0000*\u0000stitle\";s:26:\"Am. j. transplant. (Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2012\";s:9:\"\u0000*\u0000volume\";s:2:\"12\";s:8:\"\u0000*\u0000issue\";s:2:\"11\";s:8:\"\u0000*\u0000spage\";s:4:\"3021\";s:8:\"\u0000*\u0000epage\";s:4:\"3030\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1600-6135\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"WINSTON\";s:10:\"\u0000*\u0000aufirst\";s:4:\"D. J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:14:{i:0;s:9:\"SALIBA, F\";i:1;s:9:\"NAVASA, M\";i:2;s:12:\"TROISI, R. I\";i:3;s:7:\"CHEN, H\";i:4;s:13:\"VILLANO, S. A\";i:5;s:11:\"UKNIS, M. E\";i:6;s:11:\"BLUMBERG, E\";i:7;s:12:\"ABOULJOUD, M\";i:8;s:17:\"GARCIA-DIAZ, J. B\";i:9;s:10:\"GOSS, J. A\";i:10;s:9:\"CLOUGH, L\";i:11;s:8:\"AVERY, R\";i:12;s:12:\"LIMAYE, A. P\";i:13;s:13:\"ERICZON, B. G\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:202:\"Efficacy and Safety of Maribavir Dosed at 100 mg Orally Twice Daily for the Prevention of Cytomegalovirus Disease in Liver Transplant Recipients: A Randomized, Double-Blind, Multicenter Controlled Trial\";s:8:\"\u0000*\u0000place\";s:11:\"Hoboken, NJ\";s:6:\"\u0000*\u0000pub\";s:5:\"Wiley\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:32:\"10.1111\/j.1600-6143.2012.04231.x\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:202:\"Efficacy and Safety of Maribavir Dosed at 100 mg Orally Twice Daily for the Prevention of Cytomegalovirus Disease in Liver Transplant Recipients: A Randomized, Double-Blind, Multicenter Controlled Trial\";s:9:\"\u0000*\u0000jtitle\";s:43:\"American journal of transplantation (Print)\";s:9:\"\u0000*\u0000stitle\";s:26:\"Am. j. transplant. (Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2012\";s:9:\"\u0000*\u0000volume\";s:2:\"12\";s:8:\"\u0000*\u0000issue\";s:2:\"11\";s:8:\"\u0000*\u0000spage\";s:4:\"3021\";s:8:\"\u0000*\u0000epage\";s:4:\"3030\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1600-6135\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"WINSTON\";s:10:\"\u0000*\u0000aufirst\";s:4:\"D. J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:14:{i:0;s:9:\"SALIBA, F\";i:1;s:9:\"NAVASA, M\";i:2;s:12:\"TROISI, R. I\";i:3;s:7:\"CHEN, H\";i:4;s:13:\"VILLANO, S. A\";i:5;s:11:\"UKNIS, M. E\";i:6;s:11:\"BLUMBERG, E\";i:7;s:12:\"ABOULJOUD, M\";i:8;s:17:\"GARCIA-DIAZ, J. B\";i:9;s:10:\"GOSS, J. A\";i:10;s:9:\"CLOUGH, L\";i:11;s:8:\"AVERY, R\";i:12;s:12:\"LIMAYE, A. P\";i:13;s:13:\"ERICZON, B. G\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:202:\"Efficacy and Safety of Maribavir Dosed at 100 mg Orally Twice Daily for the Prevention of Cytomegalovirus Disease in Liver Transplant Recipients: A Randomized, Double-Blind, Multicenter Controlled Trial\";s:8:\"\u0000*\u0000place\";s:11:\"Hoboken, NJ\";s:6:\"\u0000*\u0000pub\";s:5:\"Wiley\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:32:\"10.1111\/j.1600-6143.2012.04231.x\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:32:\"10.1111\/j.1600-6143.2012.04231.x\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:202:\"Efficacy and Safety of Maribavir Dosed at 100 mg Orally Twice Daily for the Prevention of Cytomegalovirus Disease in Liver Transplant Recipients: A Randomized, Double-Blind, Multicenter Controlled Trial\";s:9:\"\u0000*\u0000jtitle\";s:43:\"American journal of transplantation (Print)\";s:9:\"\u0000*\u0000stitle\";s:26:\"Am. j. transplant. (Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2012\";s:9:\"\u0000*\u0000volume\";s:2:\"12\";s:8:\"\u0000*\u0000issue\";s:2:\"11\";s:8:\"\u0000*\u0000spage\";s:4:\"3021\";s:8:\"\u0000*\u0000epage\";s:4:\"3030\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1600-6135\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"WINSTON\";s:10:\"\u0000*\u0000aufirst\";s:4:\"D. J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:14:{i:0;s:9:\"SALIBA, F\";i:1;s:9:\"NAVASA, M\";i:2;s:12:\"TROISI, R. I\";i:3;s:7:\"CHEN, H\";i:4;s:13:\"VILLANO, S. A\";i:5;s:11:\"UKNIS, M. E\";i:6;s:11:\"BLUMBERG, E\";i:7;s:12:\"ABOULJOUD, M\";i:8;s:17:\"GARCIA-DIAZ, J. B\";i:9;s:10:\"GOSS, J. A\";i:10;s:9:\"CLOUGH, L\";i:11;s:8:\"AVERY, R\";i:12;s:12:\"LIMAYE, A. P\";i:13;s:13:\"ERICZON, B. G\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:202:\"Efficacy and Safety of Maribavir Dosed at 100 mg Orally Twice Daily for the Prevention of Cytomegalovirus Disease in Liver Transplant Recipients: A Randomized, Double-Blind, Multicenter Controlled Trial\";s:8:\"\u0000*\u0000place\";s:11:\"Hoboken, NJ\";s:6:\"\u0000*\u0000pub\";s:5:\"Wiley\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:32:\"10.1111\/j.1600-6143.2012.04231.x\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:202:\"Efficacy and Safety of Maribavir Dosed at 100 mg Orally Twice Daily for the Prevention of Cytomegalovirus Disease in Liver Transplant Recipients: A Randomized, Double-Blind, Multicenter Controlled Trial\";s:9:\"\u0000*\u0000jtitle\";s:43:\"American journal of transplantation (Print)\";s:9:\"\u0000*\u0000stitle\";s:26:\"Am. j. transplant. (Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2012\";s:9:\"\u0000*\u0000volume\";s:2:\"12\";s:8:\"\u0000*\u0000issue\";s:2:\"11\";s:8:\"\u0000*\u0000spage\";s:4:\"3021\";s:8:\"\u0000*\u0000epage\";s:4:\"3030\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1600-6135\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"WINSTON\";s:10:\"\u0000*\u0000aufirst\";s:4:\"D. J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:14:{i:0;s:9:\"SALIBA, F\";i:1;s:9:\"NAVASA, M\";i:2;s:12:\"TROISI, R. I\";i:3;s:7:\"CHEN, H\";i:4;s:13:\"VILLANO, S. A\";i:5;s:11:\"UKNIS, M. E\";i:6;s:11:\"BLUMBERG, E\";i:7;s:12:\"ABOULJOUD, M\";i:8;s:17:\"GARCIA-DIAZ, J. B\";i:9;s:10:\"GOSS, J. A\";i:10;s:9:\"CLOUGH, L\";i:11;s:8:\"AVERY, R\";i:12;s:12:\"LIMAYE, A. P\";i:13;s:13:\"ERICZON, B. G\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:202:\"Efficacy and Safety of Maribavir Dosed at 100 mg Orally Twice Daily for the Prevention of Cytomegalovirus Disease in Liver Transplant Recipients: A Randomized, Double-Blind, Multicenter Controlled Trial\";s:8:\"\u0000*\u0000place\";s:11:\"Hoboken, NJ\";s:6:\"\u0000*\u0000pub\";s:5:\"Wiley\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:32:\"10.1111\/j.1600-6143.2012.04231.x\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:202:\"Efficacy and Safety of Maribavir Dosed at 100 mg Orally Twice Daily for the Prevention of Cytomegalovirus Disease in Liver Transplant Recipients: A Randomized, Double-Blind, Multicenter Controlled Trial\";s:9:\"\u0000*\u0000jtitle\";s:43:\"American journal of transplantation (Print)\";s:9:\"\u0000*\u0000stitle\";s:26:\"Am. j. transplant. (Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2012\";s:9:\"\u0000*\u0000volume\";s:2:\"12\";s:8:\"\u0000*\u0000issue\";s:2:\"11\";s:8:\"\u0000*\u0000spage\";s:4:\"3021\";s:8:\"\u0000*\u0000epage\";s:4:\"3030\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1600-6135\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"WINSTON\";s:10:\"\u0000*\u0000aufirst\";s:4:\"D. J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:14:{i:0;s:9:\"SALIBA, F\";i:1;s:9:\"NAVASA, M\";i:2;s:12:\"TROISI, R. I\";i:3;s:7:\"CHEN, H\";i:4;s:13:\"VILLANO, S. A\";i:5;s:11:\"UKNIS, M. E\";i:6;s:11:\"BLUMBERG, E\";i:7;s:12:\"ABOULJOUD, M\";i:8;s:17:\"GARCIA-DIAZ, J. B\";i:9;s:10:\"GOSS, J. A\";i:10;s:9:\"CLOUGH, L\";i:11;s:8:\"AVERY, R\";i:12;s:12:\"LIMAYE, A. P\";i:13;s:13:\"ERICZON, B. G\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:202:\"Efficacy and Safety of Maribavir Dosed at 100 mg Orally Twice Daily for the Prevention of Cytomegalovirus Disease in Liver Transplant Recipients: A Randomized, Double-Blind, Multicenter Controlled Trial\";s:8:\"\u0000*\u0000place\";s:11:\"Hoboken, NJ\";s:6:\"\u0000*\u0000pub\";s:5:\"Wiley\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
